U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07604675) titled 'Patient Agreement Form and Medication Abortion Knowledge' on May 11.
Brief Summary: This study evaluates whether exposure to the U.S. Food and Drug Administration (FDA)-required Patient Agreement Form (PAF) for mifepristone improves patient knowledge about medication abortion. Participants seeking medication abortion at clinical sites in the United States were randomized to complete a knowledge assessment either before or after reviewing and signing the PAF. The primary objective was to assess whether exposure to the PAF improves knowledge related to medication abortion, including medication use, effectiveness, risks, and when to see...